Drug Patent Expirations for the Week of September 10, 2023

TYZEKA (telbivudine) Novartis Patent: 7,589,079 Expiration: Sep 11, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…

The post Drug Patent Expirations for the Week of September 10, 2023 appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.